BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Phoenix Bioscience Core - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Phoenix Bioscience Core
X-ORIGINAL-URL:https://phoenixbiosciencecore.com
X-WR-CALDESC:Events for Phoenix Bioscience Core
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Phoenix
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Phoenix:20220613T080000
DTEND;TZID=America/Phoenix:20220613T090000
DTSTAMP:20260510T164254
CREATED:20220412T210034Z
LAST-MODIFIED:20220412T210034Z
UID:1931-1655107200-1655110800@phoenixbiosciencecore.com
SUMMARY:AZBioPEERS: Tales from the Road
DESCRIPTION:Featured Speaker: Tassos\, CEO\, MyoKardia who will share his journey from conception to acquisition. Register here.
URL:https://phoenixbiosciencecore.com/event/azbiopeers-tales-from-the-road/
LOCATION:Virtual
CATEGORIES:Business Focused
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Phoenix:20220621T080000
DTEND;TZID=America/Phoenix:20220621T090000
DTSTAMP:20260510T164254
CREATED:20220620T230344Z
LAST-MODIFIED:20220620T230344Z
UID:2352-1655798400-1655802000@phoenixbiosciencecore.com
SUMMARY:AZBioPEERS: Tales From The Road
DESCRIPTION:Featured Speaker: \nTassos Gianakakos – CEO\, MyoKardia \n—Please join us as Tassos discusses his journey from conception to acquisition.  MyoKardia was acquired in 2020 by Bristol Myers Squibb for $13.1 Billion in Cash. \nSince starting in vaccine research at Merck & Co. over 20 years ago\, he has been instrumental in starting-up multiple biotechnology companies focused on creating game-changing therapies.  Most recently\, he was CEO of MyoKardia\, a mission-driven company focused on changing the lives of people with serious cardiovascular disease through bold and innovative science.  MyoKardia pioneered a precision medicine approach to discovering and development novel therapies for heart conditions and was acquired by BMS in October of 2021 for $13.5 billion. \nTassos and his wife Katina grew up in Chicago and currently live with their three boys in Paradise Valley.  He has an engineering and economics degree from the Massachusetts Institute of Technology\, a graduate degree in biotechnology from Northwestern University\, and an MBA from Harvard Business School.  Tassos is currently on the board of LianBio (NASDAQ: LIAN) a leading cross-border biotechnology company on a mission to bring transformative medicines to historically underserved patients in Greater China and other Asian markets. He is a regular speaker at biotechnology industry events and as an alumni adviser to MIT\, Northwestern and Harvard Business School. \nRegister here. 
URL:https://phoenixbiosciencecore.com/event/azbiopeers-tales-from-the-road-2/
LOCATION:Virtual
CATEGORIES:Business Focused
ATTACH;FMTTYPE=image/png:https://phoenixbiosciencecore.com/wp-content/uploads/2022/06/image.png
END:VEVENT
END:VCALENDAR